Increase in government initiatives to develop antivenoms and incidents of the venomous bites in undeveloped regions are fuelling the growth of antivenom market over the forecast period. In addition, rise in deaths due to venomous bites and technological advancements in the development of antivenom creates significant opportunities for the antivenom manufacturers. However, complexity in regulatory procedures, insufficient funding in development of antivenom, and high cost of the product are hindering growth of antivenom market.A sample of this report is available upon request @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-antivenom-market/#ulp-4H8Z4LpNMLEuOnnx[/URL]
Antivenom market segmented based on product type, animal, and distribution channel
Based on product type, global antivenom market has been segmented into
Monovalent
Polyvalent
On the basis of animal, global antivenom market is segmented into
Snake
Scorpions
Spiders
Others
On the basis of distribution channel, global antivenom market is segmented into
Hospital Pharmacies
Retail Pharmacies
Others
To view TOC of this report is available upon request @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-antivenom-market/#ulp-c654SbFYO64MsOhu[/URL]
Growing demand of antivenom worldwide, especially in Africa and Asia-Pacific region owing to more number of venomous bite incidents. According to World Health Organization (WHO), about 5 Mn snake bites occur each year, resulting 2.5 Mn envenomings (poisoning because of snake bites), minimum 100,000 deaths and around three times as many amputations and other permanent disabilities. Withdrawal of antivenoms like Fav-Afrique by Pfizer further grew demand for the market. Market players are also actively involving in R&D to develop antivenoms and to enhance their market position. In addition, many market players and institutions are actively involved in the development of new antivenoms. For instance, Equine F (ab’) 2 in antivenin is being developed by Instituto Bioclon S.A (clinical trials phase 2) for treatment of poisoning by scorpion sting. Based on the aforementioned factors antivenom market is expected to grow with significant CAGR rate during the forecast period.
Need more information about this report @
[URL]https://www.precisionbusinessinsights.com/market-reports/global-antivenom-market/#ulp-14mlyhjMGhVjZqa3[/URL]
Some of the players in Antivenom Market are Vins Bioproducts Limited (India), Bharat Serum and Vaccines Limited (India), CSL Limited (Victoria), Rare Disease Therapeutics, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Instituto Bioclon, S.A. de C.V.(Mexico), Incepta Vaccine Ltd. (Bangladesh), BTG Plc (U.K), Merck & Co., Inc. (U.S), and Pfizer Inc. (U.S.), to name a few.
Precision Business Insights
Email: sales@precisionbusinessinsights.com
Toll Free(US): +1-866-598-1553